KFDA allows restricts use of Avandia diabetes drug

The Korea Food and Drug Administration says that it would impose new restrictions on the use of the diabetes drug Avandia in an effort to protect patients from the risks of cardiovascular problems.

The restrictions will require patients to sign documents indicating they are aware of the risks associated with taking the drug, and physicians will be limited to prescribing the medicine to certa...